A G Barbe1, A Heinzler1, Shm Derman1, M Hellmich2, L Timmermann3, M J Noack1. 1. Department of Operative Dentistry and Periodontology, Centre of Dental Medicine, University of Cologne, Köln, Germany. 2. Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Köln, Germany. 3. Department of Neurology, University of Cologne, Köln, Germany.
Abstract
OBJECTIVE: Parkinson's disease (PD) adversely affects oral health (OH). However, the informative value of xerostomia compared to objective parameters and its impact on quality of life (QoL) are still unclear. This study aimed to explore whether xerostomia correlates with hyposalivation and to define its impact on OH-related QoL. MATERIALS AND METHODS: Whole stimulated saliva (WSS) was collected from 30 patients with PD and 30 matched healthy controls. Objective parameters (community periodontal index of treatment needs, plaque/gingivitis index, mucosa situation and cheilitis angularis) and questionnaires (German Oral Health Impact Profile [OHIPG]-14, visual analogue scale [VAS], xerostomia [yes/no] and the Unified Parkinson's Disease Rating Scale-II) were assessed. RESULTS: Eighty-seven per cent of patients with PD showed hyposalivation vs 50% of controls (P = 0.001); 50% of patients with PD reported xerostomia, and none of controls (P < 0.001). The OHIPG-14 was impaired in patients with PD compared to controls (P < 0.001), PD patients with xerostomia reported mean VAS values of 4.1 (s.d.: 2.2). WSS did not correlate with VAS values. CONCLUSIONS: Half of the patients with PD reported xerostomia and underestimated their xerostomic status, with higher probability than healthy controls. WSS did not reflect the grade of xerostomia. Patients with PD suffered from impaired OH-related QoL. Dental teams should not overlook these oral health risks.
OBJECTIVE:Parkinson's disease (PD) adversely affects oral health (OH). However, the informative value of xerostomia compared to objective parameters and its impact on quality of life (QoL) are still unclear. This study aimed to explore whether xerostomia correlates with hyposalivation and to define its impact on OH-related QoL. MATERIALS AND METHODS: Whole stimulated saliva (WSS) was collected from 30 patients with PD and 30 matched healthy controls. Objective parameters (community periodontal index of treatment needs, plaque/gingivitis index, mucosa situation and cheilitis angularis) and questionnaires (German Oral Health Impact Profile [OHIPG]-14, visual analogue scale [VAS], xerostomia [yes/no] and the Unified Parkinson's Disease Rating Scale-II) were assessed. RESULTS: Eighty-seven per cent of patients with PD showed hyposalivation vs 50% of controls (P = 0.001); 50% of patients with PD reported xerostomia, and none of controls (P < 0.001). The OHIPG-14 was impaired in patients with PD compared to controls (P < 0.001), PDpatients with xerostomia reported mean VAS values of 4.1 (s.d.: 2.2). WSS did not correlate with VAS values. CONCLUSIONS: Half of the patients with PD reported xerostomia and underestimated their xerostomic status, with higher probability than healthy controls. WSS did not reflect the grade of xerostomia. Patients with PD suffered from impaired OH-related QoL. Dental teams should not overlook these oral health risks.
Authors: Gabriele Röhrig; Schmidt Pia; Michael Bussmann; Henning Kunter; Michael Johannes Noack; Anna Greta Barbe Journal: Eur Geriatr Med Date: 2020-03-13 Impact factor: 1.710
Authors: Nicolas Noetzel; Anna Maria Meyer; Giacomo Siri; Lena Pickert; Annika Heeß; Joshua Verleysdonk; Thomas Benzing; Alberto Pilotto; Anna Greta Barbe; Maria Cristina Polidori Journal: Eur Geriatr Med Date: 2020-11-18 Impact factor: 1.710
Authors: Ana L C Martimbianco; Fabio C Prosdocimi; Camillo Anauate-Netto; Elaine M Dos Santos; Gustavo D Mendes; Yara D Fragoso Journal: Neurol Ther Date: 2021-03-18
Authors: Anna Greta Barbe; Pia Schmidt; Michael Bussmann; Henning Kunter; Michael Johannes Noack; Gabriele Röhrig Journal: Clin Interv Aging Date: 2018-10-12 Impact factor: 4.458